Rheumatic Diseases Clinical Trial
Official title:
Investigation From Biopsychosocial Perspective of Patients With Rheumatic Disease With Covid-19 Who Participated in a Biopsychosocial Exercise Program: A Case Series With 6-Month Follow-up
Objective: This novel study aimed to interrogate from a biopsychosocial perspective the health conditions during the Covid-19 infection and long-Covid periods of 5 patients with rheumatic disease infected with Covid-19 who had acquired the habit of regular exercise before the pandemic. Method: This case study included five patients suffering from Covid-19 infection among patients with rheumatic disease who had acquired the habit of regular exercise before the Covid-19 pandemic. It was applied a questionnaire to the patients from a biopsychosocial perspective to see the short and long-term effects of Covid-19 during and after quarantine. Moreover, the study used the BETY-Biopsychosocical Questionnaire (BETY-BQ) to evaluate a biopsychosocial point, Health Assessment Questionnaire (HAQ) to measure functional status, and the Hospital Anxiety and Depression Scale (HADS) to assess anxiety and depression. Results: In BETY-BQ, HAQ, and HADS, there was an unfavorable increase in overall scores of all patients during Covid-19. After six months, although the results from these three scales improved, some of the patients could not return to their pre-covid state. Conclusions: The patients participating in the telerehabilitation were able to return to everyday life after Covid more efficiently and overcome post-Covid symptoms easily. This study is important in guiding the exercise approach for patients with rheumatic diseases in pandemics such as Covid-19.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT04976972 -
A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation
|
N/A | |
Completed |
NCT04042792 -
Characterization of Adalimumab Concentrations in Pediatric Patients With Inflammatory Rheumatic Disease With and Without Methotrexate
|
||
Recruiting |
NCT05554029 -
Coronaphobia in Rheumatic Diseases
|
N/A | |
Completed |
NCT02944448 -
A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
|
Phase 2 | |
Completed |
NCT02694796 -
Impact of Web and Smartphone-based Physical Activity Program on Physical Activity Level 12 Months After a Balneotherapy
|
N/A | |
Completed |
NCT02269254 -
Persona Versus NexGen
|
N/A | |
Completed |
NCT02256098 -
RSA RCT: ATTUNEā¢ TKA Versus PFC Sigma TKA
|
N/A | |
Completed |
NCT00642837 -
A Study on Health - Related Quality of Life in Patients With Rheumatic Diseases Taking Tramadol 37.5mg/Acetaminophen 325mg Tablets
|
Phase 4 | |
Active, not recruiting |
NCT04704544 -
Effectiveness of Tele-rheumatology for Delivering High Quality Rheumatology Care During the COVID-19 Crisis (EVOLVE)
|
N/A | |
Completed |
NCT05026853 -
Patient-Reported Outcomes Measurement Information System Integration Into Rheumatology Clinical Practice
|
N/A | |
Active, not recruiting |
NCT04631965 -
Healthcare Transition of Adolescents With Chronic Health Conditions
|
||
Recruiting |
NCT00024479 -
Natural History of Rheumatic Diseases in Minority Communities
|
||
Completed |
NCT05031104 -
Low-energy Laser Applications in Patients With Juvenile Idiopathic Arthritis
|
N/A | |
Not yet recruiting |
NCT04567576 -
Predictive Factors for COVID-19 in Rheumatology
|
||
Completed |
NCT02291471 -
Tolerance and Pharmacokinetics of T0001 in Healthy Adult Chinese Volunteers
|
Phase 1 | |
Completed |
NCT01227694 -
Adult Stem Cell Therapy for Repairing Articular Cartilage in Gonarthrosis
|
Phase 1/Phase 2 | |
Recruiting |
NCT01071447 -
Nurse-led Clinic for Patients With Rheumatic Diseases and Biological Treatment
|
N/A | |
Active, not recruiting |
NCT05618782 -
Clinical Trial to Evaluate the Efficacy and Safety of LEVI-04 in Patients With Osteoarthritis of the Knee
|
Phase 2 | |
Active, not recruiting |
NCT05543642 -
The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)
|
Phase 4 | |
Active, not recruiting |
NCT02694185 -
Secondary Event Prevention Using Population Risk Management After PCI and for Anti-Rheumatic Medications
|
N/A |